ScholarIQanswers from OpenAlex
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
PaperCitations, authors & open-access status
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes have?
ScholarIQcitation count
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes has 1,509 citations in the OpenAlex counts ScholarIQ stores.
When was Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes published?
ScholarIQyear
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes has 2020 year in the ScholarIQ index.
What is the open-access status of Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes?
ScholarIQoa status
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes?
ScholarIQdoi
The DOI for Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes is on the source record.
What is the PMID of Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes?
ScholarIQpmid
The PMID for Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes is on the source record.
What is the OpenAlex record for Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes?
ScholarIQopenalex
The OpenAlex for Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes is on the source record.